🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCagriSema (amylin + semaglutide) — my results so far Page 7

CagriSema (amylin + semaglutide) — my results so far

Dr.NutriCornell Wed, Apr 1, 2026 at 9:59 AM 31 replies 1,170 viewsPage 7 of 7
ben_calgary
Member
245
1,123
Oct 2024
Calgary, CA
Apr 7, 2026 at 3:51 AM#31
SarahChen_PharmD said:
Worth answering the question that was asked rather than the one behind it.

Coming at SarahChen_PharmD’s question from a different direction. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

If somebody has the primary source to hand I would rather cite it than paraphrase it.

32 7KetoKyle, CanadaChris, ZaraB_AL and 29 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Apr 7, 2026 at 1:30 PM#32

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Apr 7, 2026 at 7:30 PM
31 6JenPlateau, SallyK_inj, CryptoCarl and 28 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Apr 7, 2026 at 11:09 PM#33

One thing that is still open after SarahChen_PharmD’s answer:

How would you tell the difference between that and the alternative explanation?

30 5Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 27 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Apr 8, 2026 at 8:47 AM#34
HPLC_Greg said:
Keep the original post as written when you update it, and add the correction underneath.

I read this differently from HPLC_Greg, on substance rather than tone. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

Last edited: Apr 8, 2026 at 11:47 AM
29 4jennifer_SEA, tyler_CSCS, VanRx_Mike and 26 others
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Apr 8, 2026 at 6:25 PM#35
HPLC_Greg said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

28 3carlos_SATX, sophie_paris, mel_PDX and 25 others
Reply Quote Save Share Report
1567

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register